ArticleProbiotics and antimicrobial proteins2026
Probiotic Potential of Indigenous Cetobacterium somerae R9 in Mud Crab (Scylla paramamosain).
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Probiotics provide an efficient and relatively safe method for preventing disease and increasing production in aquaculture. During the screening of beneficial bacteria in the economically important mud crab (Scylla paramamosain), an indigenous gut strain, Cetobacterium somerae R9, was isolated for the first time as a butyrate producer. This study aimed to evaluate the probiotic potential of C. somerae R9 both in vitro and in vivo. In vitro assays revealed that C. somerae R9 exhibited grow at pH 7-9, NaCl concentrations of 0.5-2.5%, and bile salt concentrations of 0.4-1.0%, and displayed susceptibility to most of the antibiotics tested. In the in vivo study, dietary supplementation with C. somerae R9, either alone or in combination with prebiotics (resistant starch and galactooligosaccharides), enhanced growth, improved antioxidative status (evidenced by elevated SOD and CAT activity and reduced MDA content), reduced hepatopancreatic damage (reduced AST activity), and maintained intestinal integrity. Supplementation also selectively enriched beneficial gut microbiota (e.g., members of Fusobacteriota). Transcriptome analysis showed that C. somerae R9 appeared to activate the PI3K-Akt signaling pathway, focal adhesion, and ECM-receptor interaction, while the combination of C. somerae R9 and prebiotics activates complement and coagulation cascades, amino sugar and nucleotide sugar metabolism, and protein digestion and absorption. Furthermore, mud crabs fed diets supplemented with C. somerae R9 exhibited significantly higher survival after challenge with Vibrio parahaemolyticus, with the synbiotic providing greater benefits than the probiotic alone. These findings collectively suggest that C. somerae R9 is a promising probiotic candidate (used either alone or in combination with prebiotics) for mud crab aquaculture.
Indexed as
Identifiers
42262447What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.